You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

lymphocytic leukemia

Showing 51 - 75 of 6,274
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hypogammaglobulinemia, Bacterial Infections, B-cell Chronic Lymphocytic Leukemia Trial in Columbus, Pittsburgh (Xembify,

Recruiting
  • Hypogammaglobulinemia
  • +2 more
  • Columbus, Ohio
  • +1 more
Jan 16, 2023

Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia Trial in

Recruiting
  • Recurrent Chronic Lymphocytic Leukemia
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 17, 2022

Chronic Lymphocytic Leukemia Trial (Evaluation of response to treatment with response-tailored Ibrutinib in patients with

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • Evaluation of response to treatment with response-tailored Ibrutinib in patients with chronic lymphocytic leukemia
  • (no location specified)
Dec 27, 2022

Non-hodgkin Lymphoma, Acute Lymphoblastic Leukaemia, Chronic Lymphocytic Leukemia Trial in Tianjin (CC312)

Recruiting
  • Non-hodgkin Lymphoma
  • +2 more
  • CC312
  • Tianjin, Tianjin, China
    InstituteHBDH
Sep 12, 2023

Newly Diagnosed Asymptomatic High-Risk Chronic Lymphocytic

Recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • EQ-5D-5L Instrument
  • +2 more
  • Vancouver, British Columbia, Canada
  • +3 more
Dec 12, 2022

B-cell Chronic Lymphocytic Leukemia Trial in Peking (Alemtuzumab)

Suspended
  • B-cell Chronic Lymphocytic Leukemia
  • Alemtuzumab
  • Peking, Beijing, China
    Peking University Cancer Hospital
Jun 15, 2022

Venetoclax Resistance Landscape in Chronic Lymphocytic Leukemia

Recruiting
  • Chronic Lymphocytic Leukemia
  • +4 more
    • Bobigny, France
    • +8 more
    Mar 23, 2022

    Relapsed Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia Trial in Poland, United

    Recruiting
    • Relapsed Non Hodgkin Lymphoma
    • +6 more
    • Cincinnati, Ohio
    • +4 more
    Aug 3, 2022

    Autoimmune Hemolytic Anemia, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial (Ibrutinib 420 mg)

    Not yet recruiting
    • Autoimmune Hemolytic Anemia
    • +3 more
    • Ibrutinib 420 mg
    • (no location specified)
    Jan 12, 2023

    Chronic Lymphocytic Leukemia, COVID-19 Infection Trial in Duarte (Biospecimen Collection, mRNA COVID-19 Vaccine, Synthetic

    Not yet recruiting
    • Chronic Lymphocytic Leukemia
    • COVID-19 Infection
    • Biospecimen Collection
    • +2 more
    • Duarte, California
      City of Hope Medical Center
    Jan 3, 2023

    Hematopoietic and Lymphoid Cell Tumor, Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in

    Not yet recruiting
    • Hematopoietic and Lymphoid Cell Neoplasm
    • +5 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 10, 2022

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial run by the (Acalabrutinib (Arm A), Acalabrutinib (Arm B))

    Active, not recruiting
    Has Results
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • Acalabrutinib (Arm A)
    • Acalabrutinib (Arm B)
    • Bethesda, Maryland
      Research Site
    Jan 3, 2023

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Boston (Venetoclax, Obinutuzumab, Rituximab)

    Recruiting
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Dec 5, 2022

    Chronic Lymphocytic Leukemia (CLL) Trial in United States (Venetoclax, Obinutuzumab, Acalabrutinib)

    Active, not recruiting
    • Chronic Lymphocytic Leukemia (CLL)
    • Stamford, Connecticut
    • +4 more
    Dec 2, 2022

    Recurrent Chronic Lymphocytic Leukemia, Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Recurrent Small

    Recruiting
    • Recurrent Chronic Lymphocytic Leukemia
    • +4 more
    • Jacksonville, Florida
      Mayo Clinic in Florida
    Mar 22, 2022

    Leukemia Trial in Houston (Pirtobrutinib, Obinutuzumab, Venetoclax)

    Not yet recruiting
    • Leukemia
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 7, 2022

    Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma Trial in New York (Ibrutinib, Pembrolizumab)

    Recruiting
    • Chronic Lymphocytic Leukemia
    • Mantle Cell Lymphoma
    • New York, New York
      Icahn School of Medicine at Mount Sinai
    Aug 22, 2022

    B-type Chronic Lymphocytic Leukemia Subgroups: Maturation Stage

    Active, not recruiting
    • Chronic Lymphocytic Leukemia
      • Manhasset, New York
        Feinstein Institute for Medical research
      Jul 6, 2022

      Recurrent Chronic Lymphoid Leukemia Trial in Boston (ACY-1215, Ibrutinib, Idelalisib)

      Active, not recruiting
      • Recurrent Chronic Lymphoid Leukemia
      • Boston, Massachusetts
        Dana Farber Cancer Institute
      Dec 19, 2022

      Small Lymphocytic Leukemia (SLL), Chronic Lymphocytic Leukemia (CLL) Trial run by the NHLBI (Duvelisib, Ibrutinib)

      Terminated
      Has Results
      • Small Lymphocytic Leukemia (SLL)
      • Chronic Lymphocytic Leukemia (CLL)
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Feb 15, 2022

      Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia Trial in

      Active, not recruiting
      • Stage I Chronic Lymphocytic Leukemia
      • +3 more
      • Jacksonville, Florida
        Mayo Clinic in Florida
      Mar 24, 2022

      Chronic Lymphocytic Leukemia (CLL) Trial in United States (Obinutuzumab, Venetoclax)

      Recruiting
      • Chronic Lymphocytic Leukemia (CLL)
      • Basking Ridge, New Jersey
      • +6 more
      Jan 3, 2023

      Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Columbus (Acalabrutinib, Obinutuzumab, Venetoclax)

      Recruiting
      • Chronic Lymphocytic Leukemia
      • Small Lymphocytic Lymphoma
      • Columbus, Ohio
        Ohio State University Comprehensive Cancer Center
      Nov 2, 2022

      Chronic Lymphocytic Leukemia Trial in Boston, Hackensack, New York (Ublituximab, Umbralisib, Ibrutinib)

      Active, not recruiting
      • Chronic Lymphocytic Leukemia
      • Boston, Massachusetts
      • +2 more
      Aug 19, 2022

      Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial (BGB-21447)

      Not yet recruiting
      • Relapsed Non-Hodgkin Lymphoma
      • +6 more
      • (no location specified)
      Apr 12, 2023